FÇFurkan Çetin

Furkan Çetin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Furkan Çetin has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predicting the risk of cesarean hysterectomy in the management of placenta accreta spectrum disorders: a new model based on clinical findings and ultrasonography

    by İbrahim Taşkum, Furkan Çetin, Seyhun Sucu, Muhammed Hanifi Bademkıran, Özge Kömürcü Karuserci, Cihan Bademkıran, Hüseyin Çağlayan Özcan

    Purpose To develop a nomogram to predict the probability of cesarean hysterectomy (CH) in placenta accreta spectrum disorders (PASD) patients. Methods Data from 520 patients who underwent surgery with a preliminary diagnosis of PASD at a tertiary center in southeast Turkey between 2013 and 2023 were collected, and 302 patients were included in the study. A predictive model based on clinical and ultrasonographic variables was developed using penalized maximum likelihood estimation (PMLE) regression analysis. Results Maternal age (aOR = 1.22, 95% CI 1.08–1.44, p = 0.001) and prior uterine surgeries (aOR = 3.18, 95% CI 1.57–8.29, p = 0.001) were identified as demographic factors with an increased likelihood of CH in the nomogram, and advanced gestational weeks demonstrated a negative correlation (aOR: 0.78, 95% CI 0.56–1.02, p = 0.07). Regarding the ultrasonographic findings, the presence of the “multiple lacunae within the placenta” (aOR = 48.53, 95% CI 18.42–257.40, p < 0.001) and the “anterior placental location” (aOR = 9.60, 95% CI 2.96–50.76, p < 0.001) significantly increased the probability of CH. In addition, “hypervascularization on Doppler flow with irregularity in the line between the bladder and uterine serosa” (aOR = 7.90, 95% CI 2.66–35.12, p < 0.001) and the “retroplacental myometrial thickness of < 1 mm” (aOR = 2.49, 95% CI 0.89–8.27, p = 0.08) were related to the probability of CH. Harrell’s C-index was 0.974, and the kappa value was 0.819 for the prediction model’s performance evaluation. Conclusion We developed a nomogram to predict the probability of cesarean hysterectomy in patients with PASD, incorporating maternal age, gestational weeks, prior uterine surgeries, ultrasound findings, and placental location. The most closely associated findings with CH in patients with PASD were the presence of multiple placental lacunae and the anterior location of the placenta.


  • Open Access

    A novel predictive model of lymphovascular space invasion in early-stage endometrial cancer

    by İbrahim Taşkum, Muhammed Hanifi Bademkıran, Furkan Çetin, Seyhun Sucu, Erkan Yergin, Özcan Balat, Halil Özkaya, Evren Uzun

    To predict lymphovascular space invasion (LVSI) positivity in early-stage (stage 1-2) endometrial cancer (EC) using a predictive model with prognostic factors of EC. We included 461 patients who underwent total hysterectomy and bilateral salpingo-oophorectomy with pelvic-paraaortic lymphadenectomy as the primary treatment for presumed early-stage EC at our clinic between 2010 and 2020. Moreover, all surgical specimens were examined histopathologically for the positivity or negativity of LVSI, and the patients were divided into two groups based on these pathologic outcomes. Age, menopausal status, histological type (type 1-2), histological grade (grades 1-2-3), depth of myometrial invasion, and peritoneal cytology results were recorded and analyzed as clinicopathological and demographic characteristics of the patients. The Loess algorithm determined the relationship between the observed and predicted outcomes. The distinction between the algorithms was evaluated by calculating the C-index. LVSI positivity was significantly associated with advanced age, menopause, type 2 EC, advanced histological grade, malignant peritoneal cytology, cervical involvement, and a tumor exceeding 50% of the myometrial depth (p<0.001, respectively). Remarkably, LVSI was most strongly associated with three explanatory variables: 1- More than 50% myometrial invasion [odds ratio (OR): 3.78; 95% confidence interval (CI): 1.80-7.60], 2- Advanced histological grade [OR=1.98 (1.20-3.20) 95% CI], 3- Malignant peritoneal cytology [OR= 3.06 (1.40-6.30) 95% CI]. The penalized maximum likelihood estimation model correctly classified 87% of the included patients (C-index: 0.876). Our predictive model may help predict LVSI based on different prognostic factors. The prognostic factors included in the nomogram were significantly associated with LVSI, particularly myometrial invasion depth of more than 50%, advanced histological grade, and malignant peritoneal cytology.


  • Retraction
    Open Access

    Retraction Note: A Modified Technique of Laparoscopic Closed-Entry by the Veress Needle: A Novel, Unique, Rapid, and Simple Procedure

    by Seyhun Sucu, Özge Kömürcü Karuserci, İbrahim Taşkum, Furkan Çetin, Muhammed Hanifi Bademkıran, Hüseyin Çağlayan Özcan

    The authors request the withdrawal of the technical research paper titled “A Modified Technique of Laparoscopic Closed-Entry by the Veress Needle: A Novel, Unique, Rapid, and Simple Procedure” which was published in the Eur J Ther [1]. This request is made on behalf of all authors involved. The authors regret that the reason for retraction was that a conflict of interest arose between them. Consequently, the conflict of interest made the manuscript unsuitable for publication in its current form. The authors apologize for any inconvenience this may cause.

  • Retracted
    Open Access

    A Modified Technique of Laparoscopic Closed-Entry by the Veress Needle: A Novel, Unique, Rapid, and Simple Procedure

    by Seyhun Sucu, Ozge Kömürcü Karuserci, İbrahim Taşkum, Furkan Çetin, Muhammed Hanifi Bademkıran, Hüseyin Çağlayan Özcan

    Background: Gynecologists usually perform the laparoscopic closed-entry technique to access the intraperitoneal cavity, while general surgeons prefer the open-entry approach, which takes more time. This study aims to introduce and discuss the novel modified closed laparoscopic entry technique. This method involves cutting the fascia after the skin incision to allow only the Veress needle to enter, thus avoiding complications arising from the closed procedure. This approach may benefit safe and quick laparoscopic entry, especially for obese patients. Method of Technique: The current approach, which we call the modified closed Veress technique (MCVT), is a modification of the previously defined Veress needle entrance method. After the skin is cut, the subcutaneous fat tissue is released with the Mosquito clamp, the muscular fascia is held and hung with the Kocher clamp, and the incision is created large enough to insert the Veress needle. Then, the Veress needle is passed through the parietal peritoneum, the final step before reaching the intraperitoneal cavity. Results: In our Gynecology and Obstetrics clinic, the current technique for the first entrance to the intraperitoneal cavity was used in a total of 294 patients between the years 2019-2023. There were no intraoperative or postoperative complications associated with the current approach. Moreover, in 12 patients who failed with the standard closed technique, intraperitoneal gas charging was provided in the first trial with the MCVT. Conclusion: Because it is possibly as safe as the open technique and as quick as the standard closed technique, the MCVT may be one of the alternative techniques for the first laparoscopic entry into the peritoneal cavity to prevent complications and save time. Nevertheless, more thorough and patient-based prospective randomized research is required on this topic.


  • Open Access

    The potential role of preoperative cystoscopy for determining the depth of invasion in the placenta accreta spectrum

    by Furkan Çetin, Seyhun Sucu, Hüseyin Çağlayan Özcan, Özge Kömürcü Karuserci, Çağdaş Demiroğlu, Muhammed Hanifi Bademkiran, Emin Sevinçler

    Objectives: This study aims to determine the role of preoperative cystoscopy in specifying the degree of placental invasion to the bladder in the placenta accreta spectrum (PAS), especially in percreta. Material and methods: This prospective observational cohort study included 78 PAS patients. All included patients underwent the preoperative cystoscopy before the cesarean hysterectomy operation. The preoperative cystoscopy procedure identified markers of PAS as neovascularization, arterial pulsatility in neovascularized zones, and posterior bladder wall bulging. Then the patients were divided into subgroups according to the histopathological results of their cesarean hysterectomy specimens. Finally, the histopathological subgroups of PAS were estimated using preoperative cystoscopy signs in the designed logistic regression analysis model. Results: The preoperative cystoscopic signs such as neovascularization, the posterior bladder wall bulging, and the arterial pulsatility in neovascularized zones were approximately associated with a 17-fold [OR = 16.9 (95% CI, 5.7–49.8)], 26-fold [OR = 26.1 (95% CI, 8.17–83.8)], and 9-fold [OR = 8.94 (95% CI, 2.94–27.1)] increase in the likelihood of placenta percreta, respectively. Conclusions: Preoperative cystoscopy may significantly contributions to other standard imaging modalities to identify the degree of placental invasion, especially placenta percreta. Experienced obstetricians trained in hysteroscopic visualization may safely perform this preoperative cystoscopy procedure under the guidance of a specialist urologist. Accordingly, it may be possible to estimate the degree of invasion and the course of surgery in patients with PAS using the preoperative cystoscopy procedure. Objectives: This study aims to determine the role of preoperative cystoscopy in specifying the degree of placental invasion to the bladder in the placenta accreta spectrum (PAS), especially in percreta. Material and methods: This prospective observational cohort study included 78 PAS patients. All included patients underwent the preoperative cystoscopy before the cesarean hysterectomy operation. The preoperative cystoscopy procedure identified markers of PAS as neovascularization, arterial pulsatility in neovascularized zones, and posterior bladder wall bulging. Then the patients were divided into subgroups according to the histopathological results of their cesarean hysterectomy specimens. Finally, the histopathological subgroups of PAS were estimated using preoperative cystoscopy signs in the designed logistic regression analysis model. Results: The preoperative cystoscopic signs such as neovascularization, the posterior bladder wall bulging, and the arterial pulsatility in neovascularized zones were approximately associated with a 17-fold [OR = 16.9 (95% CI, 5.7–49.8)], 26-fold [OR = 26.1 (95% CI, 8.17–83.8)], and 9-fold [OR = 8.94 (95% CI, 2.94–27.1)] increase in the likelihood of placenta percreta, respectively. Conclusions: Preoperative cystoscopy may significantly contributions to other standard imaging modalities to identify the degree of placental invasion, especially placenta percreta. Experienced obstetricians trained in hysteroscopic visualization may safely perform this preoperative cystoscopy procedure under the guidance of a specialist urologist. Accordingly, it may be possible to estimate the degree of invasion and the course of surgery in patients with PAS using the preoperative cystoscopy procedure.


  • Evaluation of the effect of multi-dose Methotrexate therapy on ovarian reserve in ectopic pregnancies: Is polycystic ovarian morphology a protective condition for ovarian reserve?

    by Furkan Çetin, Neslihan Bayramoglu Tepe, Ali Irfan Kutlar

    Objectives: The study aims to evaluate the effects of multi-dose methotrexate (MTX) or subsequent salpingectomy on ovarian reserve and explain the conditions that cause the change in serum anti-Müllerian hormone (AMH) levels. Material and methods: Our department had 58 tubal EP patients treated with a multiple-dose MTX protocol or subsequent salpingectomy between 2017–2020. Serum AMH level was measured in each patient before the medication and 3–6 months after therapy. Patients' details were recorded and analyzed later. Results: The mean AMH value decreased in 32 patients (−17.8%), increased in 26 patients (+31.5%) (p < 0.0001). In the group with an increase, there was a rather high number of patients with a polycystic ovary (PCO) condition compared to the other group (p = 0.0001). AMH values increased in patients with PCO and decreased in patients having no PCO (p < 0.001). Conclusions: Multiple-dose MTX or subsequent salpingectomy treatment in tubal ectopic pregnancy (EP) patients might not refer to significant differences in patients' AMH levels. Remarkably, post-treatment AMH levels were significantly increased in EP patients with PCO and decreased in those without this condition. PCO may be a protective condition for ovarian reserve. Objectives: The study aims to evaluate the effects of multi-dose methotrexate (MTX) or subsequent salpingectomy on ovarian reserve and explain the conditions that cause the change in serum anti-Müllerian hormone (AMH) levels. Material and methods: Our department had 58 tubal EP patients treated with a multiple-dose MTX protocol or subsequent salpingectomy between 2017–2020. Serum AMH level was measured in each patient before the medication and 3–6 months after therapy. Patients' details were recorded and analyzed later. Results: The mean AMH value decreased in 32 patients (−17.8%), increased in 26 patients (+31.5%) (p < 0.0001). In the group with an increase, there was a rather high number of patients with a polycystic ovary (PCO) condition compared to the other group (p = 0.0001). AMH values increased in patients with PCO and decreased in patients having no PCO (p < 0.001). Conclusions: Multiple-dose MTX or subsequent salpingectomy treatment in tubal ectopic pregnancy (EP) patients might not refer to significant differences in patients' AMH levels. Remarkably, post-treatment AMH levels were significantly increased in EP patients with PCO and decreased in those without this condition. PCO may be a protective condition for ovarian reserve.


  • Open Access

    Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

    by Furkan Çeti̇n, Neslihan Bayramoğlu Tepe, Seyhun Sucu, Muhammed Hanifi Bademkiran, İrFan Kutlar

    Purpose: The study aimed at determining the success rate of sequential multi-dose methotrexate treatment in tubal ectopic pregnancy (EP) patients and the prognostic factors affecting the treatment success. Materials and Methods: Clinical, laboratory, and demographic data of 63 patients -hospitalized with the diagnosis of EP in our tertiary center between 2017-2020 and administered sequential multiple-dose methotrexate treatment protocol- were analyzed in this retrospective study. Results: Based on research findings, medical treatment was successful in 45 of the patients. It was found that 16 out of 18-patient, 88.8% of the patients in the failed group with methotrexate treatment, were operated on due to tubal rupture during follow-up. The mean of sonographic free fluid in Douglas of the successful group with methotrexate treatment was found to be 2.40±0.70 mm (Mean±SE), while it was 10.38±3.05 mm (Mean±SE) in the failed group at the first consultation. The initial β-hCG value of the successful group with methotrexate treatment was measured 3668.55±440.55 IU/L (Mean±SE), while it was 4929.72±752.65 IU/L (Mean±SE) in the failed group. Conclusion: The success rate of the sequential multiple dose methotrexate protocol was 71.4%. Both the initial serum β-hCG level and the amount of sonographic free fluid in the pouch of Douglas were found high in the failed group with medical treatment at the first consultation.